Collaborative standardisation and SEP Licensing: a EU policy perspective / G. Bruzzone & S. Capozzi -- Economic considerations on mergers, IPR licensing and litigation : A EU perspective / C. Caffarra & P. Régibeau -- Alternative dispute resolution in FRAND licensing : economic considerations...

The January 2012 decision of the Italian Competition Authority (“ICA”) to fine Pfizer and Pharmacia €10.6 million is an illustration of the more aggressive trend taken by competition authorities in the pharmaceutical sector. In this case, the ICA alleges that the parties sought to delay...

Damage compensation claims in case of cartels are supposed to increase deterrence, compensate losses and increase efficiency. I show that such claims can instead have adverse effects: If suppliers or buyers of cartelists are compensated in proportion to the profits lost due to the cartel,...